Molina Healthcare (MOH) shares skyrocketed 18%, scoring one of the top performances among S&P 500 stocks on Thursday, after the health insurer reported better-than-expected results. Increased premium revenue from government-backed Medicaid plans helped drive the strong results.
Molina Healthcare, Inc. (NYSE:MOH ) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President, Chief Executive Officer Mark Keim - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research A.J. Rice - UBS Sarah James - Cantor Fitzgerald Stephen Baxter - Wells Fargo Justin Lake ...
Molina Healthcare beat Wall Street estimates for third-quarter profit on Wednesday, helped by higher premiums at its government-backed Medicaid insurance plans for the low-income population.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 (In millions, except per-s...
Certain healthcare stocks rank among the “Harris trades,” meaning stocks that could rally on a win by Democratic presidential nominee Kamala Harris. Meanwhile, small-cap banks are among the stocks that could benefit from a second Trump presidency.
Rising medical costs and poor earnings from peers like Elevance Health and UnitedHealth have spooked investors, impacting Molina's stock. MOH's upcoming Q3 earnings have downside risks if industry trends prove correct. Despite short-term risks, the Company's roll-up strategy of acquiring smaller insurers makes it a compelling GARP opportunity.
LINCOLN, Neb.--(BUSINESS WIRE)--The MolinaCares Accord and Molina Healthcare of Nebraska provide a $50,000 grant to improve health outcomes for mothers and youth living in poverty.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.